(S)-2-(6-Methylpyridin-2-yl)-4-phenyl-4,5-dihydrooxazole

Catalog No. :
ACZJYL240
CAS No. :
1308311-03-6
Molecular Formula :
C15H14N2O
Molecular Weight :
238.29

IUPAC Name:(S)-2-(6-methylpyridin-2-yl)-4-phenyl-4,5-dihydrooxazole

(S)-2-(6-Methylpyridin-2-yl)-4-phenyl-4,5-dihydrooxazole structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg97%$72.00Login to see priceIn stockInquiry
250mg97%$166.00Login to see priceIn stockInquiry
1g97%$491.00Login to see priceIn stockInquiry
5g97%$2424.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(S)-2-(6-Methylpyridin-2-yl)-4-phenyl-4,5-dihydrooxazole
IUPAC Name(S)-2-(6-methylpyridin-2-yl)-4-phenyl-4,5-dihydrooxazole
MDL No.MFCD34596662
Molecular FormulaC15H14N2O
Molecular Weight238.29
SMILESCC1=CC=CC(C2=N[C@@H](C3=CC=CC=C3)CO2)=N1
InChI KeyZBYAUOZWGYIGNW-CQSZACIVSA-N
SynonymPyridine, 2-[(4S)-4,5-dihydro-4-phenyl-2-oxazolyl]-6-methyl-;(S)-2-(6-methylpyridin-2-yl)-4-phenyl-4,5-dihydrooxazole;2-[(4S)-4,5-dihydro-4-phenyl-2-oxazolyl]-6-methyl-Pyridine
CAS No.1308311-03-6
PubChem CID53342715

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H315-H319
Precautionary Statement(s)
P264-P280-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362+P364

Synthetic Route by SureRoute

1. ACZJYL240 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACCYVO619 route compound structure diagram
    ACCYVO6195315-25-3 In Stock
  4. Then
  5. ACZJYL240 route product structure diagram
    ACZJYL2401308311-03-6 In Stock
Inquiry

2. ACZJYL240 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACZJYL240 route product structure diagram
    ACZJYL2401308311-03-6 In Stock
Inquiry

Comments (0)